Anna Vávrová

Comparison of Clinically Used and Experimental Iron Chelators for Protection against Oxidative Stress-Induced Cellular Injury

Petra Bendová, Eliška Macková, Pavlína Hašková et al. · Chemical Research in Toxicology · 2010 · 72 citations

Life Sciences, Pharmacology, Toxicology +17

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells

Anna Vávrová, Hana Jansová, Eliška Macková et al. · PLoS ONE · 2013 · 71 citations · Full text

Medicine, Oncology, Pharmacology +14

Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways

Eduard Jirkovský, Olga Popelová, Pavla Staňková et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 55 citations

Medicine, Cardiology, Pharmacology +17

Synthesis and Initial <i>in Vitro</i> Evaluations of Novel Antioxidant Aroylhydrazone Iron Chelators with Increased Stability against Plasma Hydrolysis

Kateřina Hrušková, Petra Kovařı́ková, Petra Bendová et al. · Chemical Research in Toxicology · 2011 · 55 citations

Life Sciences, Biochemistry, Chemistry +17

Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity

Pavlína Hašková, Petra Kovařı́ková, Lucie Koubková et al. · Free Radical Biology and Medicine · 2010 · 48 citations

Medicine, Chemistry, Pharmacology +9